Page 4 - நிறுவன நெறிமுறைகள் குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நிறுவன நெறிமுறைகள் குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நிறுவன நெறிமுறைகள் குழு Today - Breaking & Trending Today

Coronavirus: Bharat Biotech says volunteer's death not related to vaccine


Coronavirus: Volunteer’s death not related to vaccine, says Bharat Biotech
Citing the autopsy report, the company said that the 45-year-old died due to cardio-respiratory failure, resulting from a suspected case of poisoning.
Jan 10, 2021 · 11:02 am
Image for representation: A health worker takes part in a dry run as part of preparedness for the administration of Covid-19 vaccine.
|
PTI
Pharmaceutical company Bharat Biotech on Saturday said that the death of a 45-year-old volunteer in Bhopal during the clinical trials of its coronavirus vaccine was not related to the jab, reported
The Hindu.
“The volunteer passed away nine days after the dosing and preliminary reviews by the site indicate that the death is unrelated to the study dosing,” the company said in a statement. “We cannot confirm if the volunteer received the study vaccine or a placebo as the study is blinded.” ....

Madhya Pradesh , Institutional Ethics Committee , Union Health Ministry On , National Institute Of Virology , Indian Council Of Medical Research , Bhopal Gandhi Medical College , Central Drugs Control Standards Organization , Serum Institute , Oxford University , Bharat Biotech , Gandhi Medical College , New Drugs , Clinical Trials Rules , Data Safety Monitoring , Indian Council , Medical Research , National Institute , Union Health Ministry , Bharat Biotech Clinical Trial , Man Dies During Vaccine Trial , Coronavirus Vaccine Updates , Coronavirus Vaccine News , Corona Virus , Coronavirus Vaccine , Bharat Biotech Vaccine Trial Death , மத்யா பிரதேஷ் ,

Covaxin row: Bharat Biotech clarifies allegations over volunteer who died after shot


ANI |
Updated: Jan 09, 2021 20:24 IST
New Delhi [India], January 9 (ANI): After a participant who allegedly died days after volunteering for Covaxin trial in Bhopal, Bharat Biotech on Saturday clarified that the volunteer, at the time of enrolment, had fulfilled all the inclusion and exclusion criteria to be accepted as a participant in the Phase III trial and was reported to be healthy in all the site follow up calls post seven days of his dosing.
With regard to reports of a death in Phase III trials, we would like to state that a volunteer passed away on December 21, 2020, and the death was reported to the People s College of Medical Sciences and Research Centre by the son of the deceased, Bharat Biotech stated. ....

Madhya Pradesh , New Delhi , Institutional Ethics Committee , Madhya Pradesh Police , Central Drugs Control Standards Organisation , Research Centre , People College Of Medical Sciences , Bhopal Police , Site Ethics Committee , Gandhi Medical College , Bharat Biotech , Medical Sciences , New Drugs , Clinical Trials Rules , Data Safety Monitoring Board , Good Clinical Practices , Covid 19 Vaccine , மத்யா பிரதேஷ் , புதியது டெல்ஹி , நிறுவன நெறிமுறைகள் குழு , மத்யா பிரதேஷ் போலீஸ் , மைய மருந்துகள் கட்டுப்பாடு தரநிலைகள் ஆர்கநைஸேஶந் , ஆராய்ச்சி மையம் , மக்கள் கல்லூரி ஆஃப் மருத்துவ அறிவியல் , போபால் போலீஸ் , தளம் நெறிமுறைகள் குழு ,

Volunteer's Death 'Unrelated' To Covaxin: Bharat Biotech


Volunteer s Death Unrelated To Covaxin: Bharat Biotech
We cannot confirm if the volunteer received the study vaccine or a placebo as the study is blinded, the vaccine major noted.
PTI
outlookindia.com
2021-01-09T20:56:07+05:30
After the death of a 42-year-old volunteer in Bhopal, who took a dose of Covaxin in the clinical trial of Bharat Biotech s Covaxin, further spurred controversy over the emergency approval of the firm s covid vaccine, Bharat Biotech denied that the vaccine was the cause of the volunteer s death.
Vaccine maker Bharat Biotech on Saturday said the death of a volunteer in Bhopal, who took a shot of its COVID-19 vaccine Covaxin as part of the Phase III clinical trials, was not related to the medication. ....

Madhya Pradesh , Andhra Pradesh , Institutional Ethics Committee , People College Of Medical Sciences Research Centre , Madhya Pradesh Police , Haryana Health , Bhopal Police , Central Drugs Control Standards Organization , Site Ethics Committee , Serum Institute , Gandhi Medical College , Bharat Biotech , Volunteer Dies , After Taking Bharat Biotech , Drugs Controller General , Medical Sciences , Research Centre , Covaxin Safe For , New Drugs , Clinical Trials Rules , Data Safety Monitoring Board , How Bharat Biotech , Covaxin Got Emergency Approval By Expert , Good Clinical Practices , Haryana Health Minister Anil Vij , Covaxin Death ,